Preventive effect of pocket compression device on pocket hematoma after cardiac implantable electronic device implantation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230913005

Enrollment

240

Registered

2023-09-13

Start date

2023-01-05

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patient who is undergoing CIED implantation CIED implantation Hematoma prevention Pocket compression device

Interventions

The developed pocket compression device using one-shoulder vest with pressure cuff to apply constant pressure on surgical site.,The small sandbag

Active Comparator Device,Placebo Comparator Other

Pocket compression device,Usual care

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age greater than 18 undergoing CIED implantation

Exclusion criteria

Exclusion criteria: 1. Patients with history of any psychiatric disease 2. Subjects who would not be able to come in for follow-up visits at 4-week interval 3. Refuse to participate

Design outcomes

Primary

Measure	Time frame
The pocket hematoma 24 hours and 4 weeks after implantation. Site hematoma	—

Secondary

Measure	Time frame
Adverse skin reactions 2 and 24 hours Any skin erosion or skin rash	—

Countries

Thailand

Contacts

Public ContactJakkapun Yanyongmathe

Faculty of Medicine, Chiang Mai University

palmjakkapun@gmail.com0867297927

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026